<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2017.77021</article-id><article-id pub-id-type="publisher-id">OJGas-77917</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical and Etiological Profile of Ascites in the Departmental University Hospital of Porto-Novo
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Sehonou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Finangnon</surname><given-names>Armand Wanvoegbe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aboudou</surname><given-names>Raïmi Kpossou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kouessi</surname><given-names>Anthelme Agbodande</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Albert</surname><given-names>Dovonou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marcel</surname><given-names>Zannou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fabien</surname><given-names>Houngbe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Josiane</surname><given-names>Dossou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Angelo</surname><given-names>Attinsounon</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adebayo</surname><given-names>Alassani</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Angèle</surname><given-names>Azon-Kouanou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Internal Medicine Department, HKM University Hospital, Cotonou, Benin</addr-line></aff><aff id="aff2"><addr-line>Internal Medicine Department, Departmental University Hospital, Porto-Novo, Benin</addr-line></aff><aff id="aff1"><addr-line>Hepato-Gastroenterology Department, HKM University Hospital, Cotonou, Benin</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>jsehonou@yahoo.fr(JS)</email>;<email>wafinarm@yahoo.fr(FAW)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>07</month><year>2017</year></pub-date><volume>07</volume><issue>07</issue><fpage>197</fpage><lpage>205</lpage><history><date date-type="received"><day>May</day>	<month>22,</month>	<year>2017</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>July</month>	<year>23,</year>	</date><date date-type="accepted"><day>July</day>	<month>26,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Aim: To determine the frequency, the clinical and etiological aspects of ascites in the Internal Medicine Division of the University Hospital of Porto-Novo. Methods: It was a cross-sectional study with a descriptive focus covering the period from January 16 to August 31, 2015. It covered patients hospitalized for ascites in Internal Medicine Department at the Departmental University Hospital of Porto-Novo during the study period. Data were collected on a survey sheet and entered by Excel and analyzed with SPSS. The Chisquare test was used for statistical analysis and a significance threshold of 5% was retained. Results: Of the 511 hospitalized patients during the study period, 61 (11.9%) had ascites. The mean age was 49.6 &#177; 13.6 years with extremes of 19 years and 80 years. There was a male predominance with a sex ratio of 2.05. Ascites were often type III (34 patients, 55.7%), or type II (22 patients, 36.1%). The frequent signs were hepatomegaly (65.6%), splenomegaly (45.9%), pelvic limb edema (44.3%), and abdominal collateral venous circulation (39.3%). The macroscopic appearance of the ascites fluid was dominated by citrin yellow (82%), followed by hazy (11.5%). The hematic appearance was found in 6.5% of the cases. Hepatic cirrhosis was the most frequent etiology (34.4%) followed by overall heart failure (21.0%). Hepatocellular carcinoma was found in 16% of cases and nephrotic syndrome in 10% of cases. Conclusion: The etiological diversity of ascites, found in our study, imposes a careful clinical and paraclinical approach.
 
</p></abstract><kwd-group><kwd>Ascites</kwd><kwd> Etiology</kwd><kwd> Porto-Novo</kwd><kwd> Benin</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Ascites is a fluid extravasation in the peritoneal cavity. Its etiological diagnosis requires careful clinical examination and a cautious choice of complementary examinations. Generally, ascites is a very common manifestation of decompen- sation of hepatic cirrhosis [<xref ref-type="bibr" rid="scirp.77917-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.77917-ref2">2</xref>] . Ascites decompensates 60% of cirrhosis in the first 10 years after the onset of the disease [<xref ref-type="bibr" rid="scirp.77917-ref3">3</xref>] ; the hepatic origin of ascites ranges from 75% - 85% [<xref ref-type="bibr" rid="scirp.77917-ref4">4</xref>] . In France, 80% of ascites are linked to cirrhotic hepato- pathy, mostly alcoholic-related origin [<xref ref-type="bibr" rid="scirp.77917-ref5">5</xref>] .</p><p>In Sub Saharian Africa, cirrhosis is a less frequent cause of ascites, as shown by a study in Mali in which it counted for 23.3% of cases of ascites [<xref ref-type="bibr" rid="scirp.77917-ref6">6</xref>] . In Benin in 2006, in a study of liver cirrhosis conducted in the main University Hospital of Cotonou, ascites was found in 61.53% of patients [<xref ref-type="bibr" rid="scirp.77917-ref7">7</xref>] in Hepato-gastro-Ente- rology Department. No studies have been carried out on ascites in Porto-Novo. The objective of this study was to determine the frequency, clinical and etiological aspects of ascites in Internal Medicine Department at the Departmental University Hospital of Porto-Novo.</p></sec><sec id="s2"><title>2. Methods</title><p>The study was transversal with a descriptive purpose and carried out from January 16 to August 31, 2015. The study was carried out on all hospitalized patients with ascites admitted in Internal Medicine Department at the Departmental University Hospital of Porto-Novo during the period. Were included, all patients with clinically-proved or discovered abdomino-pelvic ultrasound and confirmed during a puncture. Patients with haemoperitoneum or pyoperitoneum were not included. We conducted a systematic, non-probabilistic recruitment of all hospitalized patients with ascites in the department. Ascites was a dependent variable. Independent variables were: demographics, history, clinical and paraclinic characteristics, and etiologies. All patients included underwent an extensive physical examination and had a paraclinical assessment according to the etiological orientation of each case. No liver biopsy or laparoscopy was performed. The patients were informed about the nature of the study and the impact the results could have on their care. The fact sheets were completed in anonymity by means of an identification number guarantying the confidentiality of the data.</p><p>Data were recorded on a survey sheet and entered in Excel and analyzed with SPSS. Data processing was made with Microsoft Word 2010. The chi-square test was used for statistical analysis. The level of statistical significance retained was 5%.</p></sec><sec id="s3"><title>3. Results</title><p>A total of 511 patients were hospitalized in Internal Medicine of the Departmen- tal University Hospital of Porto-Novo. Of these patients, 61 had ascites and were booked as a sample of our study, which is a hospital prevalence of 11.9%.</p><sec id="s3_1"><title>3.1. Socio-Demographic Characteristics of the Study Population (<xref ref-type="table" rid="table1">Table 1</xref>)</title><p>The mean age was 49.6 years 13.6 with extremes 19 years and 80 years.</p><p>The sex ratio was 2.05 with a male representing 67.2% of the cases.</p><p>Patients mostly lived in urban areas 33 (54.1%) with 28 (45.9%) in rural areas. At the professional level, traders (24.6%) and craftsmen (18.0%) were the most represented.</p></sec><sec id="s3_2"><title>3.2. Clinical Characteristics</title><sec id="s3_2_1"><title>3.2.1. Distribution by Abundance of Ascites</title><p>Most patients in our sample had type III ascites (34 patients, 55.7%), followed by those with type II ascites (22, 36.1%). Type I was present in only 8% of patients.</p></sec><sec id="s3_2_2"><title>3.2.2. Distribution of Patients by Associated Signs</title><p>Forty (40) patients (65.6%) had hepatomegaly, 28 (45.9%) had splenomegaly and 27 (44.3%) had pelvic limb edema. Collateral venous circulation was associated with ascites in 39.3% (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_2_3"><title>3.2.3. Distribution According to the Macroscopic Aspect of the Liquid</title><p>The macroscopic appearance of the ascites fluid was dominated by citrin yellow (82%), followed by hazy (11.5%). The hematic appearance was found in 6.5% of the cases.</p></sec></sec><sec id="s3_3"><title>3.3. Distribution by Etiology</title><p>Hepatic cirrhosis was more prevalent in patients (34.4%) followed by overall heart failure (21.0%). Hepatocellular carcinoma was found in 16% of cases and nephrotic syndrome in 10% of cases (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Population n = 61</th></tr></thead><tr><td align="center" valign="middle" >Median age</td><td align="center" valign="middle" >49.6 (19 - 80)</td></tr><tr><td align="center" valign="middle" >Sex (M/F)%</td><td align="center" valign="middle" >67.2/32.8</td></tr><tr><td align="center" valign="middle" >Geographical zone (%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >33 (54.1)</td></tr><tr><td align="center" valign="middle" >Rural</td><td align="center" valign="middle" >28 (45.9)</td></tr><tr><td align="center" valign="middle" >Alcoholism (%)</td><td align="center" valign="middle" >25 (41.0)</td></tr><tr><td align="center" valign="middle" >Hypertension (%)</td><td align="center" valign="middle" >18 (29.5)</td></tr><tr><td align="center" valign="middle" >Smoking (%)</td><td align="center" valign="middle" >18 (29.5)</td></tr><tr><td align="center" valign="middle" >Diabetes (%)</td><td align="center" valign="middle" >4 (6.6)</td></tr><tr><td align="center" valign="middle" >History of jaundice (%)</td><td align="center" valign="middle" >3 (4.9)</td></tr></tbody></table></table-wrap><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Distribution of ascites according to etiology</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1900401x2.png"/></fig><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to ascites-associated signs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Signs</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Frequency</th></tr></thead><tr><td align="center" valign="middle" >Hepatomegaly</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >65.6</td></tr><tr><td align="center" valign="middle" >Splenomegaly</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >45.9</td></tr><tr><td align="center" valign="middle" >FE</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >44.3</td></tr><tr><td align="center" valign="middle" >C.V.C</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >39.3</td></tr><tr><td align="center" valign="middle" >Jaundice</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >27.9</td></tr><tr><td align="center" valign="middle" >HT</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >26.2</td></tr><tr><td align="center" valign="middle" >Tachycardia</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19.7</td></tr><tr><td align="center" valign="middle" >Turgescence of the jugular</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >16.4</td></tr><tr><td align="center" valign="middle" >Hyperthermia</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >13.1</td></tr><tr><td align="center" valign="middle" >Facial puffiness</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >6.6</td></tr><tr><td align="center" valign="middle" >Abdominal mass</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Digestive haemorrhages</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.6</td></tr></tbody></table></table-wrap><p>FE: Feet Edema; CVC: Collateral Venous Circulation; HT: Hypertension.</p><p>The substantial preponderance of our cirrhotic patients were male (85.7%). This male majority was also found in hepatocellular carcinoma and heart failure. But the sex ratio was equal to 1 in other etiologies. The hematic appearance of the ascites fluid was found only in peritoneal tuberculosis and cancers (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of aetiology according to macroscopic ascites fluid</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Diagnostic</th><th align="center" valign="middle"  colspan="3"  >Macroscopic aspect of ascites fluid</th></tr></thead><tr><td align="center" valign="middle" >Citrin yellow</td><td align="center" valign="middle" >Hazy</td><td align="center" valign="middle" >Hematic</td></tr><tr><td align="center" valign="middle" >Bacterial ascites</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Peritoneal tuberculosis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Hepatocellular carcinoma</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Cirrhosis</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Heart failure</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Kidney failure</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Syndrome of demons meig</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Nephrotic syndrome</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Unknown</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of patients according to the etiological profile, and clinical and biological characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Cirrhosis</th><th align="center" valign="middle" >HCC</th><th align="center" valign="middle" >HF</th><th align="center" valign="middle" >TB</th><th align="center" valign="middle" >Nephropathies</th><th align="center" valign="middle" >Unknown</th></tr></thead><tr><td align="center" valign="middle" >Mean age 40</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Sex</td></tr><tr><td align="center" valign="middle" >Male 85.7%</td><td align="center" valign="middle" >60%</td><td align="center" valign="middle" >69.2%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >50%</td></tr><tr><td align="center" valign="middle" >Female 14.3%</td><td align="center" valign="middle" >40%</td><td align="center" valign="middle" >30.8%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" >50%</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Motive for consultation</td></tr><tr><td align="center" valign="middle" >abdominal mass+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Abdominal mass-OMI</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Dyspnoea</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="6"  >Abundance of ascites</td></tr><tr><td align="center" valign="middle" >Type I</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type II+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >++</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Type III++</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="6"  >Ascites fluid aspect</td></tr><tr><td align="center" valign="middle" >Citrin yellow 100%</td><td align="center" valign="middle" >80%</td><td align="center" valign="middle" >92.3%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >25%</td></tr><tr><td align="center" valign="middle" >Unclear</td><td align="center" valign="middle" >10%</td><td align="center" valign="middle" >7.7%</td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >50%</td></tr><tr><td align="center" valign="middle" >Hematic</td><td align="center" valign="middle" >10%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >50%</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >25%</td></tr><tr><td align="center" valign="middle"  colspan="6"  >Proteins rate</td></tr><tr><td align="center" valign="middle" >Higher to 30 g</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Lower to 30 g+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr></tbody></table></table-wrap><p>HCC: Hepatocellular Carcinoma; HF: Heart Failure; TB: Tuberculosis; FE: Feet Edema.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>This transversal and descriptive study made it possible to note a hospital preva- lence of 11.94% for ascites. Our incidence is superimposable to that of Bambara [<xref ref-type="bibr" rid="scirp.77917-ref8">8</xref>] which was 11.4% in Burkina Faso in 2013, but higher than those found by Sidib&#233; [<xref ref-type="bibr" rid="scirp.77917-ref6">6</xref>] 3.68% in Mali in 2009 and Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] 3.6% in C&#244;te d’Ivoire in 2014. It is less than 75% described in 2010 by Sehonou et al. at the University Hospital of Cotonou. This high frequency in Cotonou is explained by the fact that it was a study carried out in a cirrhotic patient population.</p><p>In the present study, a male predominance was noted with a sex ratio of 2.05. This male predominance could be explained by the overexposure of men to etiological factors of cirrhosis (alcoholism, hepatitis B) which is the main cause of ascites in our series. To this could be added the relative protection of women during periods of genital activity against hepatic fibrosis: hormones play a preponderant role here. This male predominance is found in the majority of studies but in variable proportions: Drabo et al. [<xref ref-type="bibr" rid="scirp.77917-ref10">10</xref>] at Ouagadougou University Hospital in 1996, Demb&#233;l&#233; et al. [<xref ref-type="bibr" rid="scirp.77917-ref11">11</xref>] in Mali in 2009, Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] in C&#244;te d’Ivoire and Doumbia et al. [<xref ref-type="bibr" rid="scirp.77917-ref12">12</xref>] in Mali in 2012.</p><p>On the other hand, the study by Sidib&#233; [<xref ref-type="bibr" rid="scirp.77917-ref6">6</xref>] reports a sex ratio of 1.2 in favor to women.</p><p>The trend in the sex ratio of liver diseases is expected to reverse: Hepatitis B will tend to decline due to a widespread vaccination; those associated with metabolic syndrome (steatohepatitis) will tend to increase. The most affected age group in our study population is adults aged from 30 to 60 years. This age group, which represents the productive force, particularly in the developing countries, counts for 68.3% of the patients in the sample.</p><p>The most affected age groups according to Sidib&#233; [<xref ref-type="bibr" rid="scirp.77917-ref6">6</xref>] and Demb&#233;l&#233; [<xref ref-type="bibr" rid="scirp.77917-ref11">11</xref>] are respectively 20 - 40 years, 21 - 60 years. The median age of our population is 49.56 years 13.56 with 19 and 80 years as extremes, these results almost similar to those of Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] , and Bambara et al. [<xref ref-type="bibr" rid="scirp.77917-ref8">8</xref>] . The latter had found a mean age of 44.6 years with extremes: 19 and 80 years and 46.9 &#177; 16.6 years with extremes: 16 and 90 years.</p><p>The relatively young age of our patients could be explained by the etiology of ascites: in our context, the etiology of ascites is dominated by hepatopathies among which viral hepatitis (HBV) is a risk factor. Nevertheless, its transmission is mother to child related, especially horizontal during early childhood and remains long in the subclinical stage [<xref ref-type="bibr" rid="scirp.77917-ref13">13</xref>] . The most common reason for consul- tation was the increase in the volume of the abdomen (75.4%). In this case, our result is close to that of Ouattara et al. (74.7%) [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] .</p><p>The other patterns were dyspnea (13.11%), edema (8.2%) and abdominal mass (3.3%).</p><p>34 patients (55.7%) had type III ascites followed by type II ascites (22 patients, 36.1%). These results are consistent with the data of African series in relation with the delay of patients’ consultation. Demb&#233;l&#233; et al. [<xref ref-type="bibr" rid="scirp.77917-ref11">11</xref>] found 53.6% and 31% respectively for type II and type III ascites. As for Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] , they found 48.8% for type II ascites and 44.4% for type III ascites.</p><p>In fact, abdominal distension is considered in our communities as a water- filled earthenware jar mystically introduced into the abdomen [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] . Patients only go to hospital in extreme recourse, after having consulted several traditional healers unfruitfully. Hepatomegaly was the most common clinical sign, found in 65.6% of cases. Other common signs were lower extremity edema (44.3%), splenomegaly (45.9%), collateral venous circulation (39.3%), and jaundice (27.9%). Hepatomegaly was also the main morphological change reported by other authors [<xref ref-type="bibr" rid="scirp.77917-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.77917-ref14">14</xref>] . Splenomegaly and collateral venous circulations were noted in 13% and 5.5% by Bouglouga in Togo, in 28% and 30.77% by Sehonou et al. in Cotonou [<xref ref-type="bibr" rid="scirp.77917-ref7">7</xref>] .</p><p>Cirrhosis was the most frequent etiology in our study with a rate of 34.4% or one case in three, associated with a male predominance. This frequency was similar to that found by Demb&#233;l&#233; [<xref ref-type="bibr" rid="scirp.77917-ref11">11</xref>] in his series with 37.3%. Compared to our study, these series pose a problem of recruitment bias. They recruited only patients recorded in Hepato-Gastroenterology Department; on the other hand our study took place in inpatient department.</p><p>Although higher, our results were lower than those of Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] 61.9% and Kombila et al. [<xref ref-type="bibr" rid="scirp.77917-ref14">14</xref>] 44.4%. These are retrospective studies carried out over 5 years and 10 years respectively.</p><p>In France, the presence of ascites is linked to a hepatopathy, mainly cirrhotic, in 80% of cases, mainly of alcoholic origin [<xref ref-type="bibr" rid="scirp.77917-ref5">5</xref>] . This may be related to the low prevalence of viral hepatitis in France than in African countries. Heart failure was found in 21.3% of our patients. This result is higher than that of Kombila et al. [<xref ref-type="bibr" rid="scirp.77917-ref14">14</xref>] , Sidibe [<xref ref-type="bibr" rid="scirp.77917-ref6">6</xref>] who reported 9% and 7.5%, respectively. The male sex was affected as well as the female. This could be explained by the prevalence of hypertension (the main cardiovascular risk factor) in both sexes in Benin: 27.2% in men; 26.3 in women [<xref ref-type="bibr" rid="scirp.77917-ref15">15</xref>] and the recrutment of patients with cardiovascular disease in the internal Medicine department.</p><p>It is rather close to that reported by Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] 19%, women were more represented (83.4%). In a study by Traor&#233; in Mali [<xref ref-type="bibr" rid="scirp.77917-ref16">16</xref>] , on the digestive manifestations of heart failure, ascites cause was found in 11 of 35 patients with a female predominance.</p><p>In our study, a malignant transformation of cirrhosis was noted in several patients. Alpha Foeto Protein levels were elevated in 16.4% of patients. In these cases, an ultrasound has individualized hepatic nodules greater than 2 cm. Men over 60 were frequently affected. This result is consistent with the literature’s finding that CHC occurs frequently in humans and grows linearly with age. This may be related to prolonged human exposure to the viral hepatitis [<xref ref-type="bibr" rid="scirp.77917-ref17">17</xref>] . The hospital frequency of ascites due to hepatocarcinoma in Lom&#233;, according to Bouglouga et al. [<xref ref-type="bibr" rid="scirp.77917-ref18">18</xref>] was 5.1% with a male predominance (sex ratio 2.9). It was 2.54% in Abidjan for Mahassadi KA et al. [<xref ref-type="bibr" rid="scirp.77917-ref19">19</xref>] .</p><p>Nephropathies were found in 13.1% of our patients. Ouattara et al. [<xref ref-type="bibr" rid="scirp.77917-ref9">9</xref>] report in C&#244;te d’Ivoire a higher frequency than ours (17.2%). As for Kombila et al. [<xref ref-type="bibr" rid="scirp.77917-ref14">14</xref>] nephropathies counted for 7.9% of their series.</p><p>Peritoneal tuberculosis counted for 6.7% of the causes of ascites in our study. This prevalence is likely to be underestimated. Indeed, PCR (GenXpert) was performed in patients according to the diagnostic orientation. Bambara [<xref ref-type="bibr" rid="scirp.77917-ref8">8</xref>] , Kombila et al. reported a peritoneal tuberculosis incidence in 11.3% of abdomi- nal conditions and 22.7% of laparoscopic cases respectively. In the study of Mall&#233; [<xref ref-type="bibr" rid="scirp.77917-ref20">20</xref>] , abdominal tuberculosis was found in 15.07% of ascites. On the other hand, Demb&#233;l&#233; [<xref ref-type="bibr" rid="scirp.77917-ref21">21</xref>] found a lower rate of 4.13%. In Mali, a female predo-min- ance was found in the study by Traor&#233; et al. [<xref ref-type="bibr" rid="scirp.77917-ref22">22</xref>] , peritoneal involvement can be achieved from a genital focus by contiguity.</p><p>We noted 5% of indeterminate cases. No laparoscopy had been performed due to the unfavorable technical background and the limited financial resources of the patients. This exam could show granulomatosis diseases of peritoneum.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our study allowed us to have an overview of the clinical and etiological aspects of ascites in the Departmental University Hospital of Porto-Novo. This etiologi- cal diversity must therefore impose a rigorous diagnostic approach. Careful inquisition should seek the patient’s antecedents and related ascites symptoms, which have an etiological orientation value. Physical examination should not be restricted to the digestive tract as the cause may be extra digestive. These two steps will allow a difficult selection of the paraclinical examinations according to the orientation of the diagnosis.</p></sec><sec id="s6"><title>Cite this paper</title><p>Sehonou, J., Wanvoegbe, F.A., Kpossou, A.R., Agbodande, K.A., Dossou, J., Attinsounon, A., Alassani, A., Azon-Kouanou, A., Dovonou, A., Zannou, M. and Houngbe, F. (2017) Clinical and Etiological Profile of Ascites in the Departmental University Hospital of Porto-Novo. Open Journal of Gastroenterology, 7, 197- 205. https://doi.org/10.4236/ojgas.2017.77021</p></sec></body><back><ref-list><title>References</title><ref id="scirp.77917-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Soren, M., Jens, H. and Flemming, B. (2009) Ascites: Pathogenesis and Therapeutic Principles. Scandinavian Journal of Gastroenterology, 44, 902-911.  
&lt;br /&gt;https://doi.org/10.1080/00365520902912555</mixed-citation></ref><ref id="scirp.77917-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Moore, C.M. and Van Thiel, D.H. (2013) Cirrhotic Ascites Review: Pathophysiology, Diagnosis and Management. World Journal of Hepatology, 5, 251-263.  
&lt;br /&gt;https://doi.org/10.4254/wjh.v5.i5.251</mixed-citation></ref><ref id="scirp.77917-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">European Association for the Study of the Liver (2010) Clinical Practice Guidelines on the Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis. Journal of Hepatology, 53, 397-417.  
&lt;br /&gt;https://doi.org/10.1016/j.jhep.2010.05.004</mixed-citation></ref><ref id="scirp.77917-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pexa-Tittia, E., Raisinb, J. and Frenzera, A. (2012) Ascites: Etiologies, Investigations and Treatment. Forum Médical Suisse, 12, 951-954.</mixed-citation></ref><ref id="scirp.77917-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bresson-Hadni</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2000</year>)<article-title>Diagnostic Guidance and Management in the Presence of Ascites</article-title><source> Lettre de l’Hépato-Gastroentérologue</source><volume> 3</volume>,<fpage> 189</fpage>-<lpage>92</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.77917-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sidibe, A. (2009) Ascites: Clinical Presentation and Aetiological Profile of Ascites in the Department of Hepato-Gastroenterology of CHU Gabriel TOURE. Ph.D. Dissertation, University of Bamako, Bamako.</mixed-citation></ref><ref id="scirp.77917-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sehonou, J., Kodjoh, N., Sake, K. and Mouala, C. (2010) Hepatic Cirrhosis in Cotonou: Factors Related to Death. Médecine tropicale, 70, 375-78.</mixed-citation></ref><ref id="scirp.77917-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Bambara, M.L. (2013) Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects of Ascites in the Department of Medicine of the Bobo-Dioulasso University Hospital Center. Ph.D. Dissertation, Higher Institute of Health Sciences, Bobo-Dioulasso.</mixed-citation></ref><ref id="scirp.77917-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ouattara, B., Kra, O., Kouassi, L., Kone, S., Biekre, R., Toure, K.H., et al. (2014) Aetiologies of Ascites in a Department of Internal Medicine in C&amp;ocirc;te d’Ivoire. African Journal of Internal Medicine, 3, 56-59.</mixed-citation></ref><ref id="scirp.77917-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drabo</surname><given-names> Y.I.</given-names></name>,<name name-style="western"><surname> Some</surname><given-names> M.L.</given-names></name>,<name name-style="western"><surname> Kabore</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> Sawadogo</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> Lengani</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Traore</surname><given-names> R. et al. </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Morbidity and Mortality in the Internal Medicine Department of the Ouagadougou National Hospital Center over 4 Years</article-title><source> Médecine d’Afrique Noire</source><volume> 43</volume>,<fpage> 655</fpage>-<lpage>659</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.77917-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Dembele, Y. (2006) The Etiology of Ascites in the Department of Internal Medicine in the C.H.U of Point G, about 67 Cases. Ph.D. Dissertation, University of Bamako, Bamako.</mixed-citation></ref><ref id="scirp.77917-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doumbia</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> Diarra</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> Konate</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Sow</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> Soukho</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Kalle</surname><given-names> A. et al. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>Ascites, a Pejorative Complication in Cirrhotic in Tropical Environments</article-title><source> Médecine d’Afrique Noire</source><volume> 59</volume>,<fpage> 274</fpage>-<lpage>278</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.77917-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Hountondji, J.A. (1983) Morbidity and Mortality in the Department of Internal Medicine, CNHU, Cotonou. Ph.D. Dissertation, University of Abomey Calavi, Abomey Calavi.</mixed-citation></ref><ref id="scirp.77917-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kombila</surname><given-names> U.D.</given-names></name>,<name name-style="western"><surname> Iba Ba</surname><given-names> J.</given-names></name>,<name name-style="western"><surname> Obamegwa</surname><given-names> C.</given-names></name>,<name name-style="western"><surname> Mounguengui</surname><given-names> D.D.</given-names></name>,<name name-style="western"><surname> Itoudi Bignoumba</surname><given-names> E.P.</given-names></name>,<name name-style="western"><surname> Ondo Mba</surname><given-names> L.B. et al. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>Etiological Profile of Hospital-Based Ascites in Libreville</article-title><source> Médecine d’Afrique Noire</source><volume> 59</volume>,<fpage> 491</fpage>-<lpage>495</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.77917-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Houinato, D., Segnon Agueh, J.A., Djrolo, F. and Djigbennoude, O. (2008) Final Report of the STEPS Survey in Benin. National Directorate of Health Projection, National Program for the Control of Non-Communicable Diseases, Cotonou.</mixed-citation></ref><ref id="scirp.77917-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Traore, F.D. (2009) Digestive Manifestations during Heart Failure in the Medical Department of the CHU Gabriel Touré. Ph.D. Dissertation, University of Bamako, Bamako.</mixed-citation></ref><ref id="scirp.77917-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M., Konate, A., Dembele, M., Kone, B., Wandji, M.J., Maiga et al. (2006) Hepatocellular Carcinoma: Clinical and Evolutionary Epidemiological Aspects. Médecine d’Afrique Noire, 53, 23-28.</mixed-citation></ref><ref id="scirp.77917-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bouglouga, O., Bagny, A., Lawson-Ananissoh, L.M., Djibril, M.A., Redah, D. and Agbetra, A. (2012) Does the Management of Hepatocellular Carcinoma Progress in Black Africa. Revue Médicale de Madagascar, 2, 176-179.</mixed-citation></ref><ref id="scirp.77917-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Mahassadi, K.A., Attiaka, K.A., Bathaix, Y.F., Kissi, Y.H., Assohoun, K.T. and Ndri-Yoman, T.H. (2005) Clinical Manifestations and Predictive Factors of Hepatocellular Carcinoma in Abidjan (C&amp;ocirc;te d’Ivoire). Médecine d’Afrique Noire, 52, 602-608.</mixed-citation></ref><ref id="scirp.77917-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Malle, O. (2008) Abdominal Tuberculosis in the Medical Services of the CHU of Gabriel Toure and Point “G”. Ph.D. Dissertation, University of Bamako, Bamako.</mixed-citation></ref><ref id="scirp.77917-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Dembele, M, Maiga, M.Y., Minta, D.K., Traore, S.A., Sacko, M., Traore, A.K., et al. (2003) Peritoneal Tuberculosis in a Department of Internal Medicine in Tropical Environment: Clinical, Biological and Laparoscopic Aspects. Acta Endoscopica, 33, 561-567. &lt;br /&gt;https://doi.org/10.1007/BF03002421</mixed-citation></ref><ref id="scirp.77917-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Traore, A.H., Maiga, M.Y., Dembele, M., Diallo, A., Traore, A.K., Sidibe, A., et al. (1998) Current Etiologies of Abdominal Granulomatosis in Mali. Place of Laparoscopy. Médecine et Chirurgie Digestives, 27, 283-285.</mixed-citation></ref></ref-list></back></article>